These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 9049526)

  • 21. The pharmacodynamic responses of hypertensive patients to quinapril therapy.
    Fernandez PG; Snedden W
    Can J Cardiol; 1992 Mar; 8(2):189-94. PubMed ID: 1559192
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Can an angiotensin-converting enzyme inhibitor with a short half-life effectively lower blood pressure for 24 hours?
    Palatini P
    Am Heart J; 1992 May; 123(5):1421-5. PubMed ID: 1575169
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical consequences of angiotensin-converting enzyme inhibitor withdrawal in chronic heart failure: a double-blind, placebo-controlled study of quinapril. The Quinapril Heart Failure Trial Investigators.
    Pflugfelder PW; Baird MG; Tonkon MJ; DiBianco R; Pitt B
    J Am Coll Cardiol; 1993 Nov; 22(6):1557-63. PubMed ID: 8227822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antihypertensive effects and arterial haemodynamic alterations during angiotensin converting enzyme inhibition.
    London GM; Pannier B; Vicaut E; Guérin AP; Marchais SJ; Safar ME; Cuche JL
    J Hypertens; 1996 Sep; 14(9):1139-46. PubMed ID: 8986916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The safety and tolerability of quinapril.
    Knapp LE; Frank GJ; McLain R; Rieger MM; Posvar E; Singer R
    J Cardiovasc Pharmacol; 1990; 15 Suppl 2():S47-55. PubMed ID: 1691407
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quinapril: a double-blind, placebo-controlled trial in essential hypertension.
    Maclean D
    Angiology; 1989 Apr; 40(4 Pt 2):370-81. PubMed ID: 2650581
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ambulatory blood pressure monitoring can play an integral role in patient selection, dosage adjustment and efficacy assessment in clinical trials of antihypertensive agents.
    Canter DA; Texter MJ; McLain RW
    J Hypertens Suppl; 1994; 12(7):S33-8. PubMed ID: 7769502
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elimination kinetics of quinaprilat and perindoprilat in hypertensive patients with renal failure on haemodialysis.
    Yamada S; Muraoka I; Kato K; Hiromi Y; Takasu R; Seno H; Kawahara H; Nabeshima T
    Biol Pharm Bull; 2003 Jun; 26(6):872-5. PubMed ID: 12808303
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Haemodynamic response and pharmacokinetics after the first dose of quinapril in patients with congestive heart failure.
    Squire IB; Macfadyen RJ; Lees KR; Hillis WS; Reid JL
    Br J Clin Pharmacol; 1994 Aug; 38(2):117-23. PubMed ID: 7981011
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics and pharmacodynamics of quinaprilat after low dose quinapril in patients with terminal renal failure.
    Wolter K; Fritschka E
    Eur J Clin Pharmacol; 1993; 44 Suppl 1():S53-6. PubMed ID: 8387427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The rapidity of drug dose escalation influences blood pressure response and adverse effects burden in patients with hypertension: the Quinapril Titration Interval Management Evaluation (ATIME) Study. ATIME Research Group.
    Flack JM; Yunis C; Preisser J; Holmes CB; Mensah G; McLean B; Saunders E
    Arch Intern Med; 2000 Jun; 160(12):1842-7. PubMed ID: 10871979
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Albumin excretion rate and metabolic modifications in patients with essential hypertension. Effects of two angiotensin converting enzyme inhibitors.
    Puig JG; Mateos FA; Ramos TH; Lavilla MP; Capitán MC; Gil A
    Am J Hypertens; 1994 Jan; 7(1):46-51. PubMed ID: 8136110
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quinapril, hydrochlorothiazide, and combination in patients with moderate to severe hypertension.
    Lenz T; Schulte KL; Wagner B; Lilienthal J; Gotzen R
    Eur Heart J; 1994 Jul; 15(7):940-6. PubMed ID: 7925516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of the converting enzyme inhibitor quinapril (CI-906) on blood pressure, renin-angiotensin system, and prostanoids in essential hypertension.
    Säynävälammi P; Pörsti I; Pörsti P; Nurmi AK; Seppälä E; Manninen V; Vapaatalo H
    J Cardiovasc Pharmacol; 1988 Jul; 12(1):88-93. PubMed ID: 2459540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quinapril and hydrochlorothiazide combination for control of hypertension: assessment by factorial design. Quinapril Investigator Group.
    Canter D; Frank GJ; Knapp LE; Phelps M; Quade M; Texter M
    J Hum Hypertens; 1994 Mar; 8(3):155-62. PubMed ID: 8006914
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of amlodipine and quinapril on ambulatory blood pressure and platelet function in hypertension.
    Ding YA; Chang SM; Chou TC
    J Hum Hypertens; 1995 Aug; 9(8):637-41. PubMed ID: 8523379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hemodynamic and hormonal effects of quinaprilat in patients with congestive heart failure.
    Mitrovic V; Mudra H; Bonzel T; Schmidt W; Strand JC; Bakovic-Alt R; Posvar EL
    Clin Pharmacol Ther; 1996 Jun; 59(6):686-98. PubMed ID: 8681494
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quinapril versus atenolol in the treatment of mild to moderate essential hypertension.
    Bahena JH; Estrella ME; Muñoz M
    Clin Ther; 1992; 14(4):527-36. PubMed ID: 1525787
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A multicentre, double-blind, placebo-controlled trial of quinapril in mild, chronic heart failure.
    Northridge DB; Rose E; Raftery ED; Lahiri A; Elder AT; Shaw TR; Henderson E; Dargie HJ
    Eur Heart J; 1993 Mar; 14(3):403-9. PubMed ID: 8458362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The pharmacokinetics of quinapril and its active metabolite, quinaprilat, in patients with various degrees of renal function.
    Halstenson CE; Opsahl JA; Rachael K; Olson SC; Horvath AM; Abraham PA; Posvar EL
    J Clin Pharmacol; 1992 Apr; 32(4):344-50. PubMed ID: 1569237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.